Design Medical Device Clinical Trials That Fast-Track Regulatory Success
Our proven protocol development accelerates study timelines while ensuring global compliance—delivering patient-centric trial designs that regulatory authorities trust and investigators execute flawlessly.
Evidence-Backed Clinical Trial Protocol Development Built for Regulatory Success
Compliance strategies across FDA, CE marking, worldwide jurisdictions.
Global Regulatory Intelligence
Study designs that minimize burden while accelerating life-changing technology access.
Patient-Centric Architecture
Leverage insights for feasible protocols, reduced time to market globally.
Real-World Data Integration
Trial Design
Comprehensive Medical Device Clinical Trial Design Across Every Development Phase
Medical device clinical trial design demands precision at every protocol decision point. Our methodology combines regulatory intelligence with patient-centric study architecture, ensuring your clinical investigation meets global regulatory requirements while accelerating patient access to life-changing technologies.
Whether you have a medical device, IVD, or software solution, we design studies that generate compelling evidence packages and withstand regulatory scrutiny across all major jurisdictions.

Patient-Centric Protocols that Investigators can Execute Efficiently
Our comprehensive clinical trial planning services cover every aspect of protocol development, built on ISO 14155 and ISO 20916 standards to ensure worldwide acceptance of study results:
- Identification of clinical endpoints pertinent to safety and/or performance of the device
- Definition of clinical study type (e.g., significant vs. non-significant risk, superiority vs. non-inferiority/equivalence)
- Sample size considerations
- Statistical Analysis Plan (SAP) establishment
- Development of the Clinical Investigation Plan (CIP) in compliance with Good Clinical Practice (GCP)
- Assembly of Investigator's Brochure (IB)
- Selection and qualification of clinical study sites
- Structure of electronic Case Report Form (eCRF) architecture
- Compilation of other relevant components of the Trial Master File (TMF)
Core Planning Capabilities Applied Across Different Study Types
Feasibility Studies
Feasibility Studies
Trail-blazing study designs that validate device safety and performance early, incorporating adaptive methodologies to accelerate proof-of-concept while minimizing patient exposure and study costs.

Pivotal Trials
Pivotal Trials
Evidence-based pivotal study protocols engineered for regulatory success, featuring patient-centric endpoints and streamlined data collection that supports compelling 510(k)/ or PMA submissions and/or CE Marking.

Post-Market Surveillance
Post-Market Surveillance
Strategic post-market surveillance study designs that satisfy regulatory requirements while generating safety and performance data for ongoing compliance and continuous improvement.

IVD Clinical Studies
IVD Clinical Studies
Specialized in vitro diagnostic clinical evaluation protocols that meet FDA and CE marking requirements, optimizing study populations and statistical approaches for device-specific performance validation.

Real-World Evidence
Real-World Evidence
Patient-centric real-world evidence study designs that capture meaningful clinical outcomes in routine care settings, supporting regulatory submissions and payer value demonstrations.

What Clients Say
"This is terrific. First of all, I am so impressed with how quickly you turned this around. This has been a big question that our team has been grappling with for a while so this is amazing to see this come together so quickly and give us a very thorough and thoughtful response."
Jennifer Fried, CEO at Flow Medical
Meet the Team
Clinical Design Experts Who Deliver Regulatory Wins
Delphine Huser, PhD
Director, Clinical Affairs
Delphine Huser is a medical biologist with broad expertise in fundamental and applied clinical research. She obtained her PhD in Pharmacology and Toxicology from UNIL (Lausanne), where she acquired expertise in biochemistry, electrophysiology and animal experimentation. Since then, she has continuously specialized in clinical research throughout her career and excels in the regulatory environment for clinical data for medical devices. At Veranex, Delphine manages client projects involving clinical investigations in the premarket phase of medical devices and during PMCF. She is responsible for managing the clinical investigation services delivery process and ensuring its overall compliance with Good Clinical Practice requirements (ISO 14155, ISO 20916) related to quality and regulatory aspects. Delphine speaks French and English.
Tracy Case
Director, Clinical Affairs
Tracy Case is our experienced Director of Clinical Affairs. Tracy joined Veranex in 2025 and has over 15 years of experience in the medical device and life sciences industries. Prior to joining Veranex, Tracy held leadership roles at Medtronic and BD, where she led strategic initiatives in clinical evidence generation for new product development, indication expansion, and post-market surveillance. With extensive expertise in designing and managing a wide range of clinical programs, Tracy has led projects across various stages, including feasibility studies, First-In-Human (FIH) studies, pivotal studies, post-approval studies, registries, real-world evidence (RWE) studies, and investigator-initiated studies. Her experience spans a diverse set of technologies, particularly in the areas of interventional cardiology, renal denervation, coronary stents, drug-eluting balloons, advanced energy devices, breast oncology devices, implantable devices, hemostatic devices, surgical mesh, and IVD products. At Veranex, Tracy supports clients’ clinical and regulatory projects, including U.S. and international clinical study programs, from Early Feasibility Studies (EFS) to First-In-Human (FIH)/Feasibility Studies (FS) to pivotal trials and real-world evidence (RWE) initiatives in pursuit of medical device commercialization.
Anna Rydberg
Sr Clinical Study Manager
Anna Rydberg is a Senior Clinical Study Manager with 25 years of experience in clinical research from pharmaceutical and medical device industry. Anna is a biologist by training and holds a PhD in Medical Microbiology and Immunology. She has a broad background in clinical study design and strategic planning for clinical development, spanning from single-center pilot studies to multi-center, post-market clinical studies across various therapeutic areas, both in EU and US. Additional expertise includes pharmacovigilance, regulatory affairs, data management, medical writing and clinical evaluations.
Case Studies
Medical Device Clinical Trial Design Success Stories, From Protocol to Approval
Real-World Impact Through Evidence-Based Study Architecture
Optimizing Protocol Design and Execution Without Compromise
Situation
A computational ECG mapping system for FDA clearance in a 510(k) submission. Sponsor needed guidance on design and endpoint identification.
Successes
- Revamped study design to use least burdensome approach and optimize endpoints
- Extracted high-volume enrollment through strong relationships with KOLs and sites
- Ran a nimble, quality-first study with data pushing them to take 1st position in market share
Services by Veranex
- Study Design & Optimization
- Study Management & Monitoring
- Safety Management
- Data Management
- Biostatistics
- Medical Writing
Discover More
Related Services at Veranex
Clinical Trial Management
Clinical Trial Management
End-to-end clinical trial execution that transforms your evidence-backed protocols into regulatory-grade data packages.

Real World Evidence
Real World Evidence
Patient-centric real-world evidence strategies that strengthen your regulatory submissions and unlock reimbursement pathways through compelling clinical outcomes data.

EU MDR Consulting
EU MDR Consulting
Smart compliance strategies that accelerate CE marking timelines while ensuring your clinical evidence package meets notified body expectations.

FDA Consulting
FDA Consulting
Evidence-based FDA submission strategies that fast-track 510(k) and PMA approvals through regulatory intelligence and submission optimization expertise.

Accelerate Your Medical Device Clinical Trial Design Timeline
Transform clinical development into regulatory-grade evidence packages.



